Back to Agenda
Measuring the effectiveness of risk minimisation measures
Session Chair(s)
Patrick Batty
, Medicines and Healthcare Products Regulatory Agency, United Kingdom
Assessing the effectiveness of risk minimisation measures after they are implemented is an important aspect of risk management. This session will cover the key principles of measuring for measuring RMM effectiveness, and provide an opportunity to discuss challenges faced and approaches to address these.
Speaker(s)
Catarina Isabel Antunes Martins
Global RMP Group Head, Novartis Pharma AG, Switzerland
Measuring effectiveness of risk minimisation measures
Patrick Batty
, Medicines and Healthcare Products Regulatory Agency, United Kingdom
James Milligan
Vice President Pharmacovigilance and Risk Management, Seqirus UK Limited, United Kingdom
Joanne Treacy, MSc
Risk Management Consultant, JBTHealthSolutions, United Kingdom
Have an account?